PREPARATION METHOD FOR AND CRYSTAL FORM OF 3-ARYLOXY-3-FIVE-MEMBERED HETEROARYLPROPYLAMINE COMPOUND

CRYSTAL FORMS OF CRENOLANIB AND METHODS OF USE THEREOF

PYRIDAZINONE COMPOUNDS

SOLID FORMS COMPRISING (S)-2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE AND SALTS THEREOF, AND COMPOSITIONS COMPRISING AND METHODS OF USING THE SAME

PROCESS FOR PREPARING A TETRAZOLE-SUBSTITUTED ANTHRANILIC ACID DIAMIDE DERIVATIVE

COMPOSITIONS OF AJULEMIC ACID AND USES THEREOF

Trientine tetrahydrochloride and a method of preparation and a pharmaceutical composition thereof

METHOD FOR PRODUCING REDUCED COENZYME Q10 FORM II CRYSTALS

2,3,5-TRIMETHYL-6-NONYLCYCLOHEXA-2,5-DIENE-1,4-DIONE FOR SUPPRESSING AND TREATING ALPHA-SYNUCLEINOPATHIES, TAUOPATHIES, AND OTHER DISORDERS

CRYSTALLINE FORM OF ASPACYTARABINE

INDOLO HEPTAMYL OXIME ANALOG CRYSTAL AS PARP INHIBITOR AND METHOD FOR PREPARING SAME

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

CRYSTAL FORM OF PYRROLO HETEROCYCLIC DERIVATIVE AND PREPARATION METHOD THEREFOR

CRYSTAL OF PYRIMIDINE COMPOUND

Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use

Method for the production of lumateperone and its salts

SOLID FORMS OF (R)-1(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL)-N-(1-(2,3-DIHYDROXYPROPYL)-6-FLUORO-2-(1-HYDROXY-2-METHYLPROPAN-2-YL)-1H-INDOL-5-YL)CYCLOPROPANECARBOXAMIDE

EGFR inhibitors

Compound having cyclic structure

PPARG inverse agonists and uses thereof

Crystal forms of 2-[4-[(2,3,4-trimethoxyphenyl)methyl]piperazin-1-yl]ethyl pyridine-3-carboxylate

CRYSTALLINE DIMETHYL TRYPTAMINE ANALOGUES

Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin

CRYSTALLINE FORM OF HETEROBICYCLIC COMPOUND

SOLID FORMS, PHARMACEUTICAL COMPOSITIONS AND PREPARATION OF HETEROAROMATIC MACROCYCLIC ETHER COMPOUNDS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

SOLID STATE FORMS OF AT-001 AND PROCESS FOR PREPARATION THEREOF

Crystal form of azaindole derivative and use thereof

CRYSTAL OF COMPOUND X7 HYDROCHLORIDE AND ITS PREPARATION METHOD AND APPLICATION

Stable salt and crystal forms of 2-[3-({1-[2-(dimethylamino)ethyl]-2-(2,2-dimethylpropyl)-1H-1,3-benzodiazol-5-yl}sulfonyl)azetidin-1-yl]ethan-1-ol

SOLID FORMS OF A COT INHIBITOR COMPOUND

SOLID FORM OF PYRAZINE SUBSTITUTED NICOTINAMIDE, AND PREPARATION AND USE THEREOF

SALT OF ARYLAMINOQUINAZOLINE-CONTAINING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF

Olaparib oxalic acid cocrystals and their pharmaceutical use

CRYSTALLINE FORMS OF PITAVASTATIN CALCIUM

CRYSTAL FORM OF QUINOLINE COMPOUND AND PROCESS FOR ITS PRODUCTION

CRYSTALLINE COMPLEXES

CRYSTALLINE EDG-2 RECEPTOR ANTAGONIST AND METHODS OF MAKING

Composite Form of Tetraacetylenediamine

SALTS AND POLYMORPHS OF CETHROMYCIN FOR THE TREATMENT OF DISEASE

MCL-1 INHIBITOR FORMULATIONS

SALT FORMS AND SOLVATES OF MCI-1 ANTAGONISTS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof

SALT OF NUCLEOSIDE ANALOG, AND CRYSTAL FORM, PHARMACEUTICAL COMPOSITION AND USE THEREOF

Salts Of Nitrogen-Containing Heterocyclic Compound, And Solid Forms Of Salts, Pharmaceutical Composition And Use Thereof

NOVEL SALTS, CRYSTALS, AND CO-CRYSTALS

SOLID FORMS OF (Z)-METHYL 3-(((4-(N-METHYL-2-(4-METHYLPIPERAZIN-1-YL)ACETAMIDO)PHENYL)AMINO)(PHENYL)METHYLENE)-2-OXO-2,3-DIHYDRO-1H-PYRROLO[2,3-B]PYRIDINE-6-CARBOXYLATE AND SALTS THEREOF

CRYSTALLINE FORM OF HYDROCHLORIDE SALT OF QUINOLINE DERIVATIVE

SALT OF 2-(SUBSTITUTED PYRIMIDINYL) THIAZOLE CARBOXAMIDE COMPOUND, AND COMPOSITION AND USE THEREOF

SALT OF RHO-ASSOCIATED PROTEIN KINASE INHIBITOR, SOLID FORM OF THE SALT, PREPARATION METHOD FOR SAME, AND USES THEREOF

SOLID STATE FORMS OF CYANTRANILIPROLE

PROCESS FOR THE PREPARATION OF TAUTOMERIC FORMS OF SUNSCREENS

POLYMORPHIC FORMS OF A ROR INHIBITING COMPOUND AND PROCESSES FOR ITS PREPARATION

PROCESS FOR THE PREPARATION OF BIHETEROARYL COMPOUNDS AND CRYSTAL FORMS THEREOF

Crystalline salt forms of mesembrine

CRYSTALLINE FORMS OF CFTR MODULATORS

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

18-MC SALT FORMS

CRYSTALLINE FORM OF TLR8 AGONIST

SOLID FORMS OF A PARP14 INHIBITOR

Crystalline forms of carbazole inhibitors of RhoGTPase for the treatment of disease

Crystalline substituted pyrazines as PGI2 receptor agonists

Crystalline freebase forms of a biphenyl compound

BROMODOMAIN INHIBITOR

COMBINATIONS FOR THE TREATMENT OF CANCER

PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR

METHODS OF PRODUCING CRYSTALLINE BETA NICOTINAMIDE RIBOSIDE TRIACETATE CHLORIDE

METHOD FOR PRODUCING ALLULOSE CRYSTALS

D-allose crystal and production method thereof

Diaryl macrocycle polymorph

SALT AND CRYSTAL FORM OF PYRIMIDINE COMPOUND, AND PREPARATION METHODS THEREFOR

SALT FORM AND CRYSTAL FORM OF JAK INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF

CRYSTALLINE FORMS OF 4-[(7-CHLORO-2-METHOXYBENZO[B][1,5]NAPHTHYRIDIN-10-YL)AMINO]-2,6-BIS(PYRROLIDIN-1-YLMETHYL)PHENOL AND SALTS THEREOF

SOLID FORMS OF PRALSETINIB

PROCESS OF MAKING A CRYSTALLINE EDG-2 RECEPTOR ANTAGONIST

RXR agonist salt form, polymorphs thereof, and uses thereof

CRYSTALLINE SUGAR COMPOSITE POWDER AND METHODS FOR MAKING THE SAME

Method for preparing crystalline D-psicose

SUCCINATE SALTS OF OCTAHYDROTHIENOQUINOLINE COMPOUND AND CRYSTALS THEREOF

Solid forms of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[1,5-a] [1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine as aryl hydrocarbon receptor (AHR) inhibitors

CRYSTALINE FORMS OF AN O-GLYCOPROTEIN-2-ACETAMIDO-2-DEOXY-3-D-GLUCOPYRANOSIDASE INHIBITOR

AROMATIC SPIRO RING AMIDE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

Substituted tetrahydrofurans as modulators of sodium channels

METHODS OF SYNTHESIZING DEUTERATED SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS

IMPROVED CHLORANTRANILIPROLE PROCESS THROUGH USE OF A CRYSTAL INTERMEDIATE

Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitor

Dihydromyricetin nanocrystals and preparation method and application thereof

SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE

PROCESS FOR PREPARATION OF TRIAZOLE COMPOUND

CRYSTALLINE FORMS OF 4-(7-HYDROXY-2-ISOPROPYL-4-OXO-4H-QUINAZOLIN-3-YL)-BENZONITRILE AND FORMULATIONS THEREOF

Phenylcarbamate crystalline form and method for manufacturing the same

POLYMORPHIC FORMS OF (R)-OXYBUTYNIN HYDROCHLORIDE

METHOD FOR THE PURIFICATION OF VILANTEROL TRIFENATATE

Crystalline salt forms

Salts of Remdesivir

Co-crystals or salts of psilocybin and methods of treatment therewith

POLYMORPHS OF A GABAA ALPHA5 AGONIST AND METHODS OF USING IN THE TREATMENT OF COGNITIVE IMPAIRMENT

Solid forms of tabernanthalog monofumarate salt for treating neurological disorders and/or psychiatric disorders

SOLID STATE FORMS OF AVAPRITINIB SALTS

SOLID FORMS, SALTS, AND PROCESSES OF PREPARATION OF A CDK2 INHIBITOR

Polymorphs of Crystalline Forms of 3,10-dimethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinolin-9-yl 3-fluorobenzenesulfonate and Salts Thereof

SOLID STATE FORMS OF N-[2-(2-{4-[2-(6,7-DIMETHOXY-3,4-DIHYDRO-2(1H)-ISOQUINOLINYL)ETHYL]PHENYL}-2H-TETRAZOL-5-YL)-4,5-DIMETHOXYPHENYL]-4-OXO-4H-CHROMENE-2-CARBOXAMIDE MESYLATE SALT

Isoindolinone inhibitors of the MDM2-P53 interaction and process for making them

SOLID FORM OF COMPOUND

STABLE POLYMORPH OF R-MDMA HCL

Crystalline forms of 3-substituted 1,2,4-oxadiazole

PREPARATION OF TRIFAROTENE AND INTERMEDIATES AND POLYMORPHS THEREOF

ALPHA, BETA-UNSATURATED ALDEHYDE PRODUCTION METHOD

Forms of aticaprant

Crystalline or Amorphous form of Bcl-2/Bcl-xL inhibitor compound or its salts

Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydropyrido [3,2-B][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-α]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms therof

Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrrolo[2,1- f][1,2,4]triazin-4-yl)piperazinyl)-pyrimidin-5-yl)ethan-1-amine and methods of making

SOLID STATE FORMS OF FEZOLINETANT AND SALTS THEREOF

SALT AND CRYSTAL FORM OF DIHYDROPYRIDO[2,3-d]PYRIMIDINE DERIVATE

SALT AND CRYSTAL FORM OF KETOHEXOKINASE INHIBITOR AND USE THEREOF

PROCESS FOR THE PREPARATION OF 6-(CYCLOPROPANEAMIDO)-4-((2-METHOXY-3-(1-METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL)AMINO)-N-(METHYL-D3)PYRIDAZINE-3-CARBOXAMIDE

Inhibitors of APOL1 and methods of using same

CRYSTALLINE FORMS OF GSK1278863, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF

POLYMORPHS OF PHENYL PYRROLE AMINOGUANDIUM SALTS

PURIFICATION OF WOOD ACETYLATION FLUID

COMBINATIONS OF GABAA ALPHA 5 AGONISTS AND SV2A INHIBITORS AND METHODS OF USING IN THE TREATMENT OF COGNITIVE IMPAIRMENT

SALTS AND FORMS OF A WEE1 INHIBITOR

Crystalline forms of a MAGL inhibitor

Method of the preparation of fused multicyclic compounds

MODULATORS OF ALPHA-1 ANTITRYPSIN

Solid forms of 1-((S)-4-((R)-7-(6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl)-6-chloro-8-fluoro-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)quinazolin-4-yl)-3-methylpiperazin-1-yl)prop-2-en-1-one

CRYSTALLINE FORM OF LNP023

SOLID STATE FORMS OF 6-CARBOXY-2-(3, 5-DICHLOROPHENYL)-BENZOXAZOLE OF FORMULA-I AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF

CRYSTALLINE FORMS OF BENZAMIDE COMPOUND AND PROCESS FOR PREPARING THE SAME

CRYSTALLINE FORM OF PHENTERMINE HYDROCHLORIDE AND PROCESS FOR OBTAINING SAME

Crystal of tefluthrin, preparation method therefor and use thereof

SOLID FORMS OF N-[2,4-BIS(1,1-DIMETHYLETHYL)-5-HYDROXYPHENYL]-1,4-DIHYDRO-4-OXOQUINOLINE-3-CARBOXAMIDE

METHOD FOR EFFICIENTLY EXTRACTING AND SEPARATING HIGH-PURITY TETRODOTOXIN FROM PUFFERFISH VISCERA

SALT AND SOLID FORMS OF TABERNANTHALOG

THE CRYSTALLINE FORMS OR AMORPHOUS FORMS OF BISDIAZABICYCLIC COMPOUNDS OR SALTS THEREOF

Polymorphs of the hydrochloride salt of linaprazan glurate

COMPOUNDS, COMPOSITIONS AND METHODS

Crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1H-indole-7-carbonitrile

Crystalline and salt forms of PPAR agonist compounds

CRYSTALLIZATION OF CANNABINOIDS

CIS-PARA-SUBSTITUTED CYCLOHEXYLAMINONITRILE SALT, PREPARATION METHOD THEREFOR AND USE THEREOF, AND METHOD FOR PREPARING PESTICIDE USING SAME

METHODS OF TREATING COVID-19 USING BARDOXOLONE METHYL OR ANALOGS THEREOF

CDK9 inhibitors and polymorphs thereof for use as agents for treatment of cancer

Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

SOLID FORMS OF APOL1 INHIBITOR AND METHODS OF USING SAME

CRYSTALS

Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide

Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-N-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate

Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate

CRYSTALLINE FORMS OF A JAK2 INHIBITOR

CRYSTALS OF 3-HYDROXYPROPIONATE AND PROCESS OF RECOVERING 3-HYDROXYPROPIONIC ACID

Methods of making bempedoic acid and compositions of the same

COMPOSITIONS COMPRISING (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRA-HYDROPYRAZOLO[1,5-a]PYRIMIDINE-3-CARBOXAMIDE

Polymorphs of (1S,2S,3S,5R)-3-((6-(Difluoromethyl)-5-Fluoro-1,2,3,4-Tetrahydroisoquinolin-8-YL)OXY)-5-(4-Methyl-7H-Pyrrolo[2,3-D]Pyrimidin-7-YL)Cyclopentane-1,2-DIOL Mono-Hydrochloride

Polymorphs of selinexor

Polymorphs of Selinexor

Crystalline form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-n-(methyl-D3) pyridazine-3-carboxamide

PROCESS, COMPOSITIONS, AND CRYSTALLINE FORMS OF SUBSTITUTED PYRIDINONE-PYRIDINYL COMPOUNDS

Solid forms

CRYSTALLINE FORMS OF SOLVATES OF TRYPTOPHAN DERIVATIVES, COMPOSITIONS COMPRISING THEM AND USES THEREOF

SQUALAMINE CRYSTALLINE POLYMORPHS

Crystal forms of crisaborole in free form and preparation method and use thereof

Co-crystal compounds comprising lithium ions and isonicotinamide

CRYSTALLINE SALT OF ERIBULIN

METHODS OF MAKING WEE1 INHIBITOR COMPOUNDS

N-[8-(2-HYDROXYBENZOYL)AMINO]POTASSIUM OCTANOATE CRYSTAL POLYMORPH, AND PREPARATION METHOD THEREFOR AND USE THEREOF

FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS

SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYLPHENYL)-N-[(1S)-2-CYCLOPROPYL-1-(3-FLUORO-4-METHYLPHENYL)ETHYL]-5-METHYL-N-PROP-2-YNYL-1,3-THIAZOL-2-AMINE

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

ORAL FORMULATION COMPRISING A CRYSTALLINE FORM OF RABEXIMOD

METHOD FOR PREPARING A CRYSTALLINE FORM OF RABEXIMOD

Solid forms of(Z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid

Phenethylamine compounds salts, polymorphic forms and methods of use thereof

SOLID STATE FORMS OF ENSARTINIB AND ENSARTINIB SALTS

CRYSTALLINE FORMS OF DELTAMETHRIN AND METHODS OF USE THEREOF

Process for the preparation of sodium (2r,5s,13ar)-7,9-dioxo-10-((2,4,6,-trifluorobenzyl)carbamoyl)-2,3,4,5,7,9,13,13A-octahydro-2,5-methanopyrido[1′,2′:4,5]pyrazino[2,1-B] [1,3] oxazepin-8-olate and its polymorphic form

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

LSD DERIVATIVES, SYNTHESIS & METHOD FOR TREATMENT OF DISEASES AND DISORDERS

PROCESS FOR THE PREPARATION SALTS OF TRIAZOLE COMPOUNDS

PROCESS FOR SYNTHESIZING 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)-PYRIDIN-3-YL)METHOXY)BENZALDEHYDE

CRYSTALLINE FORMS OF {2-[3-CYCLOHEXYL-3-(TRANS-4-PROPOXY-CYCLOHEXYL)-UREIDO]-THIAZOL-5-YLSULFANYL}-ACETIC ACID AND USES THEREOF

SALTS OR CO-CRYSTALS OF {2-[3-CYCLOHEXYL-3-(TRANS-4-PROPOXY-CYCLOHEXYL)-UREIDO]-THIAZOL-5-YLSULFANYL}-ACETIC ACID AND USES THEREOF

Sodium 2-[(4S)-8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4H-quinazolin-4-yl]acetate monohydrate, its preparation and use

A METHOD OF PRODUCING A CRYSTALLINE FORM OF SODIUM 2-[(4S)-8-FLUORO-2-[4-(3-METHOXYPHENYL)PIPERAZIN-1-YL]-3-[2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL]-4H-QUINAZOLINE-4-YL]ACETATE TRIHYDRATE

FORMS AND COMPOSITIONS OF A BETA ADRENERGIC AGONIST

SALTS OF NEUROCEUTICALS AND USES THEREOF

Combinations for Treatment of NAFLD/NASH and Related Diseases

Complex Containing Betaine, Transition Metal and Sulfate

CRYSTALLINE RET INHIBITOR

Process for the Production of Ferroportin Inhibitors

METHOD FOR PRODUCING NITROFURANTOIN ANHYDRATE, AND PRODUCT THEREOF

Polymorphs of herbicidal sulfonamides

Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators

PREPARATION OF AN SELECTIVE ESTROGEN RECEPTOR DEGRADER

CRYSTALLINE FORM OF CAPSID PROTEIN ASSEMBLY INHIBITOR CONTAINING N HETERO FIVE-MEMBERED RING, AND APPLICATION THEREOF

METHODS FOR THE PREPARATION OF SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATORS AND SOLID FORME THEREOF

Crystalline dipeptides useful in the synthesis of elamipretide

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1- carboxamide and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-n-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]-pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

CRYSTALLINE FORMS OF A SULFONAMIDE COMPOUND AND PROCESSES FOR PREPARING THE SAME

SALT AND CRYSTAL FORMS OF GLP-1R AGONISTS AND USES THEREOF

Method for preparing 2-chloro-n-(1-cyanocyclopropyl)-5-[2'-methyl-5'-(pentafluoroethyl)-4'-(trifluoromethyl)-2'h-1,3'-bipyrazol-4-yl]benzamide

SOLID FORMS OF A PLASMA KALLIKREIN INHIBITOR AND SALTS THEREOF

PRALSETINIB PHARMACEUTICAL COMPOSITIONS

SOLID FORMS OF FASORACETAM

PHENETHYLAMINE COMPOUNDS SALTS, POLYMORPHIC FORMS AND METHODS OF USE THEREOF

BENZISOXAZOLE DERIVATIVE

Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

CO-CRYSTAL OR SALT

PROCESS FOR THE PREPARATION OF CYSTEAMINE BITARTRATE AND PRODUCT SO OBTAINED

PROCESS FOR THE OXIDATION OF PRIMARY ALCOHOLS TO CARBOXYLIC ACIDS

TWO-DIMENSIONAL CHALCOGENIDE, AND PREPARATION METHOD AND USE THEREOF

INHIBITION OF NIDOVIRUSES THAT ENCODE NSP15

PROCESS FOR CRYSTALLIZING 2'-FUCOSYLLACTOSE AND RELATED COMPOSITIONS

SUNLIGHT-POWERED ROLLING CRYSTALS

SALTS AND SOLID FORMS OF AN FGFR INHIBITOR AND PROCESSES OF PREPARING THEREOF

JAK INHIBITOR COMPOUND AND USE THEREOF

Solid forms of pyrazolo[3,4-d]pyrimidine compounds

MESYLATE SALTS OF HETEROCYCLIC CYTOKININS, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF

Crystal forms of a POL1 inhibitor

CRYSTALLINE FORMS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

Novel Therapeutic Methods

Isotopologues salts, crystalline forms, stereoisomers, of methylone and ethylone and methods of use thereof

Semi synthetic method for dihydroquercetin

CRYSTALLINE SALT FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL)PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE

Formulations of T-type calcium channel modulators and methods of use thereof

CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE

1,4-DIOXANE SLOVATE OF LITHIUM DIFLUOROBIS(OXALATO)PHOSPHATE, METHOD FOR PREPARING THE SAME, AND ELECTROLYTE COMPOSITION COMPRISING THE SAME

SCALABLE POLYPROPIONATE LACTONE STEREOTETRADS

CRYSTALLINE FORMS OF RET INHIBITOR AND PREPARATION THEREOF

Crystal Form of Macrocyclic Tyrosine Kinase Inhibitor and Preparation Method therefor

Crystal Form Of Thiofuran Pyridazine Compound, Preparation Method Therefor And Application Thereof

Processes for the preparation of (3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]- pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide and solid state forms thereof

CRYSTAL OF A HYPOXANTHINE COMPOUND

CRYSTALLINE FORMS OF AN APOPTOSIS-INDUCING AGENT

SOLID STATE FORMS OF AMG-510 AND PROCESS FOR PREPARATION THEREOF

PHARMACEUTICAL COMPOSITION IN WHICH PRODUCTION OF IMPURITIES IS SUPPRESSED

TETRAHYDROCOCANNABINOLIC ACID COCRYSTALS

COCRYSTALS OF (1R,3S)-3-(5-CYANO-4-PHENYL-1,3-THIAZOL-2-YLCARBAMOYL)CYCLOPENTANE CARBOXYLIC ACID

CRYSTALLINE FORM OF OZANIMOD HYDROCHLORIDE

Olaparib hydroxybenzoic acid cocrystals and their pharmaceutical use

NOVEL SULFOBETAINE MONOMERS, PROCESS FOR PREPARING SAME, AND USES THEREOF

Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof

Methods for making and using endoxifen

Synthesis of Vinyl Cyclobutyl Intermediates

Methods of making bempedoic acid and compositions of the same

CO-CRYSTAL OF GABAPENTIN, KETOPROFEN AND LYSINE, PHARMACEUTICAL COMPOSITIONS AND THEIR MEDICAL USE

RADIO-AND CHEMO-PROTECTIVE COMPOUNDS

SOLID FORM OF MACROCYCLIC COMPOUND, PREPARATION THEREFOR AND USE THEREOF

Method of treatment of symptoms of menopause

SALT AND CRYSTAL FORMS OF 4-AMINO-5-(6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZO[D]IMIDAZOL-2-YL)THIENO[2,3-B]PYRIDIN-6(7H)-ONE

PHARMACEUTICALLY ACCEPTABLE ACID SALT OF FREE BASE OF GLP1 RECEPTOR AGONIST, AND PREPARATION METHOD THEREFOR

CRYSTALLINE FORM A OF GLP-1 RECEPTOR AGONIST AND PREPARATION METHOD THEREFOR

FREE BASE CRYSTALS

Inhibitors of the menin-MLL interaction

Methods for antagonizing a melanocortin 4 receptor

CRYSTALLINE FORMS AND FORMULATIONS OF A VCP/p97 INHIBITOR

CRYSTAL OF TRIFLUOROMETHYL/CHLORO DISUBSTITUTED SULFONAMIDE SELECTIVE BCL-2 INHIBITOR

POLYMORPHS OF A HYDROCHLORIDE SALT OF PN6047

Benzisoxazole Sulfonamide Derivatives

PROCESS FOR PREPARATION OF 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALDEHYDE

Crystal form of 2-methyl-2-propanol and amino-substituted aryl compound

Crystalline Forms of (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenol hydrochloride

Fospropofol Salts, Methods And Compositions

Solid state forms of voclosporin

FORMS AND COMPOSITIONS OF INHIBITORS OF PLASMA KALLIKREIN

POLYMORPHS AND SOLID FORMS OF (S)-2-((2-((S)-4-(DIFLUOROMETHYL)-2-OXOOXAZOLIDIN-3-YL)-5,6-DIHYDROBENZO[F]IMIDAZO[1,2-D][1,4]OXAZEPIN-9-YL)AMINO)PROPANAMIDE, AND METHODS OF PRODUCTION

CRYSTALLINE FORMS OF GEPOTIDACIN

CRYSTAL OF IMIDAZOPYRIDINONE COMPOUND OR SALT THEREOF

CRYSTALS, PREPARATION METHOD AND APPLICATION OF A MUSCARINIC RECEPTOR ANTAGONIST

VORUCICLIB POLYMORPHS AND METHODS OF MAKING AND USING THEREOF

SOLID STATE FORMS OF APROCITENTAN AND PROCESS FOR PREPARATION THEREOF

BCKDK INHIBITORS AND/OR DEGRADERS

Crystal forms of immunomodulators

Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof

AXL KINASE INHIBITORS AND USE OF THE SAME

Pseudomonas strains and their metabolites to control plant diseases

Enhanced perovskite materials for photovoltaic devices

CRYSTALLINE FORMS OF SQUALAMINE

Solid forms of substituted benzoxaborole and compositions thereof

Method for preparation of Asenapine

PYRAZOLO[3,4-d]PYRIMIDIN-3-ONE DERIVATIVE AS WEE-1 INHIBITOR

CRYSTALLINE FORMS OF 3-CYANO-1-[4-[6-(1-METHYL-1H-PYRAZOL-4-YL)PYRAZOLO[1,5-A]PYRAZIN-4-YL]-1H-PYRAZOL-1-YL]CYCLOBUTANEACETONITRILE, AND USE THEREOF

Crystalline composition of tildacerfont and methods of use and preparation thereof

CRYSTALLINE FORMS OR AMORPHOUS FORMS OF N-(PHENYL SULFONYL) BENZAMIDE COMPOUNDS OR ITS SALTS OR SOLVATES

HDAC inhibitor solid state forms

HDAC inhibitor solid state forms

CRYSTALLINE FORMS OF A TYK2 INHIBITOR

NOVEL FORMS OF PRACINOSTAT DIHYDROCHLORIDE

METHOD FOR PRODUCING NITROGEN-CONTAINING HETEROARYLCARBOXAMIDE ACETIC ACID DERIVATIVE

Crystalline form of 1-(5-(2,4-Difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-n-methylmethanamine salt

PROCESS FOR SYNTHESIZING SULFONATED TRIARYL METHANE COMPOUNDS

CHEMICALLY TUNABLE OPTICALLY ADDRESSABLE MOLECULR-SPIN QUBIT AND ASSOCIATED METHODS

Crystal form, preparation method, and application of 4'-substituted nucleoside

Compounds and methods for treatment of viral infections

Psilocybin and O-acetylpsilocin, salts and solid state forms thereof